Walmart Observes Sales Shift Due to Weight Loss Drugs

Walmart notes changes in food purchases among users of the popular weight loss drug Ozempic, predicting broader market impacts.

Walmart Observes Sales Shift Due to Weight Loss Drugs
Walmart notes changes in food purchases among users of the popular weight loss drug Ozempic, predicting broader market impacts. Photo by Marques Thomas.


Walmart U.S. CEO John Furner commented on a perceived shift in food buying patterns among consumers using weight loss drugs like Ozempic, observing a slight reduction in the overall food basket and calorie intake. As these appetite-curbing drugs gain traction, projections suggest that 7% of the U.S. population might use them by 2035. However, a counterpoint by @DisruptorStocks suggests that these GLP-1 drugs are being wrongfully blamed. They highlight that year-over-year volume changes in various food categories are down across the board, not solely due to appetite suppression in a segment of the population.

Source: Forbes & @DisruptorStocks

Great! Youā€™ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to FreightCaviar.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.